The BioHub Podcast

Same spot but today JPM is officially in full swing! 💥 The city is buzzing! Sun is shining ☀️And most importantly the meetings are so productive. So good to be seeing so many familiar please - If you see me, say hi! 👋 The BioHub Podcast Avetix Group

We’ve arrived in San Francisco for the JPM Conference (after a long 30 hours of travel). If you’re in town and would like to meet up, shoot me a message! t.weir@avetixgroup.com Thomas Hall Max Brennan, MSc

Here we are in San Francisco for #JPM! Stay with us for content throughout the week! And the best thing? The sun is shining, unlike last year! Shoot me a message to meet The BioHub Podcast Avetix Group Thomas Hall Tom Weir

And here we are - Avetix Group at JPM in San Fran. To summarise, we’re at the biggest BioTechnology professional gathering globally with the two leading global consultants in this sector pushing the Avetix Group brand further into the Life Science industry. Collectively we have close to 100 meetings confirmed… here we go. ——————————————————————— More information is to be published regarding our target growth plans this year BUT Facetime with clients is of #1 priority. Already more than 50% of the company has confirmed global travel plans in the first half of the year. Tom Weir Max Brennan, MSc

Starting 2025 with a BANG at Avetix Group. Tomorrow I travel to JPM in San Francisco with the BIOTECH team. Collectively we have 100+ meetings confirmed... We're in it to Win it! Mostly importantly, I'm excited to meet our partners face-to-face and to celebrate the success we had during 2024. AND also to meet new contacts who we aim to collaborate with over the coming 12 months. Max Brennan, MSc Tom Weir

🎙️ From mAb to CAR-T - Jason Bock dives into it all on our new episode of The BioHub Podcast Years ago when mAbs were new, lots of mistakes and triumphs occurred, but it is what we do with the success of those to focus on new medicines. Jason Bock has been through it all from early day mAbs, to now focussing on CAR-T. He dives into: ✨ The learning from mAbs to CAR-T 💼 How CTMC - a joint venture between Resilience + MD Anderson Cancer Center is successful at what they do 🔬 An insight into his career path and what makes a successful leader across different sized companies This is a really exciting watch, and I personally learned a lot from it - plus the bonus of the excitement the future holds in the biotech space 👀 👇 Check out the links below in the comments - Spotify and Youtube #thebiohub #mAb #CAR-T #futuremedicine

What a year for The BioHub! Catchup next week at #JPM!

🎉 The BioHub Podcast is 1 Year Old! 🎉 What a year it’s been! We started with a vision, and look at what we’ve achieved together: 🔥 Over 6,500 views 🏆 Top 20% of Video Podcasts on Spotify 🎥 First LIVE Event at #JPM coming soon 🌟 HR/People Spin-Out in the works Not to mention 38 incredible guests who have shared their insights and journeys with us: ➡️Marc de Garidel - Abivax ➡️Paul Peter Tak, MD PhD FMedSci - Candel Therapeutics ➡️Owen Hughes - XOMA ➡️Frank Watanabe - Arcutis Therapeutics ➡️Michael Parini - Spur Therapeutics ➡️Laurent Audoly - PriveBio ➡️Christina Trojel-Hansen PhD - Stealth ➡️Someit Sidhu ➡️Stanley T. Lewis, MD, MPH - A28 Therapeutics ➡️Matthew Shaulis - Now Beigene ➡️Tushar Pandey ➡️Michael Tusche, Ph.D., M.B.A - Now 3io Therapeutics ➡️David Slack - impilo Therapeutics ➡️Angelo Stracquatanio III - Apprentice.io ➡️Martin Taylor - F-Prime ➡️Kevin Warner, PharmD - Heron Therapeutics ➡️Nicole Lambert - Arcus Biosciences ➡️Christopher Haqq - Elicio Therapeutics ➡️Daniel Couto - Vedanta Therapeutics ➡️Rob Etherington - Clene Nanomedicine ➡️Charmaine Lykins - Now Stealth ➡️Raphaël G. Ognar, MSc MBA - NKILT Therapeutics ➡️Jerry McLaughlin - Life Biosciences ➡️Barbara Ryan - Various ➡️Chris Mirabelli - Leap Therapeutics ➡️TJ Cradick, Ph.D. - Now Huidagene Therapeutics ➡️David J. Mazzo, Ph.D. - Lisata Therapeutics ➡️Jason Lettmann - ALX Oncology ➡️Stella K. Vnook - Likarda ➡️Arjun Goyal, M.D. - Vida Ventures ➡️Ravneesh Sachdev - Apple Tree Partners ➡️Amit Kumar - Anixa Biosciences ➡️Sophia Lugo - Radar Therapeutics ➡️Greg Kunst - Aurion Biotech ➡️Joe Payne - Arcturus Therapeutics ➡️Adrian (Ad) Rawcliffe - Adaptimmune ➡️Douglas Love - Annexon Biosciences And there’s more! We have 9 amazing episodes already recorded and lined up for release: ➡️David-Alexandre "DA" Gros - Eledon Pharmaceuticals ➡️Uwe Schoenbeck - Canaan Partners ➡️Jason Bock - CTMC ➡️David Esposito - ONL Therapeutics ➡️Erick J. Lucera - Editas Medicine ➡️Sam Clark, MD PhD - Terran Biosciences ➡️Aoife Brennan - ClimBio ➡️Adam Mostafa - X4 Pharmaceuticals ➡️Mark Mallon - George Medicines Thank you so much for your support—you’ve helped make this possible! 🙏 Please keep shouting about us, sharing your feedback, and suggesting how we can improve. 🚀 See you all next week at #JPM! The BioHub Podcast and Avetix Group will be there—come say hi! 💡 Haven’t subscribed yet? What are you waiting for? #TheBioHub #Podcast #Biotech #Innovation #Leadership #JPM2024

🚀 $15𝐊 𝐚𝐧𝐝 𝐚 𝐃𝐫𝐞𝐚𝐦! 🚀 Joe Payne, CEO of Arcturus Therapeutics, shares how they started with just $15,000 and 2 months runway to build something extraordinary. 💡 “𝘞𝘦 𝘸𝘦𝘳𝘦 𝘣𝘰𝘰𝘵𝘴𝘵𝘳𝘢𝘱𝘱𝘦𝘥, 𝘦𝘯𝘵𝘳𝘦𝘱𝘳𝘦𝘯𝘦𝘶𝘳𝘪𝘢𝘭, 𝘢𝘯𝘥 𝘧𝘰𝘶𝘯𝘥𝘦𝘥 𝘰𝘯 𝘨𝘳𝘦𝘢𝘵 𝘴𝘤𝘪𝘦𝘯𝘤𝘦 𝘢𝘯𝘥 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯. 𝘛𝘩𝘢𝘵’𝘴 𝘢 𝘣𝘪𝘨 𝘱𝘢𝘳𝘵 𝘰𝘧 𝘰𝘶𝘳 𝘤𝘶𝘭𝘵𝘶𝘳𝘦 𝘵𝘰𝘥𝘢𝘺.” An inspiration for anyone strapped for cash but looking to make a real impact! 🔥 Catch the full episode—link in the comments! 🎙️ Remember we are at #JPM next week, reach out to get involved!! #TheBioHub #Podcast #Biotech #Innovation #JoePayne #ArcturusTherapeutics The BioHub Podcast

🚀 𝐅𝐫𝐨𝐦 𝐚𝐧 𝐢𝐝𝐞𝐚 𝐰𝐢𝐭𝐡 $15,000 𝐭𝐨 𝐭𝐡𝐞 𝐰𝐨𝐫𝐥𝐝’𝐬 𝐟𝐢𝐫𝐬𝐭 𝐬𝐞𝐥𝐟-𝐚𝐦𝐩𝐥𝐢𝐟𝐲𝐢𝐧𝐠 𝐦𝐑𝐍𝐀 𝐂𝐎𝐕𝐈𝐃 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 🚀 🎙️The BioHub Podcast with Joe Payne is now LIVE! 🎙️ With #JPMWeek just around the corner, what better time to dive into the incredible Arcturus story? Joe Payne, CEO of Arcturus Therapeutics, shares how they’ve become a leader in mRNA medicines and vaccines—and what’s next! 💡 Get inspired ahead of #JPM—links in the comments! Oh, and don’t forget, The BioHub Podcast LIVE from JPM is coming your way! 🎥 #TheBioHub #Podcast #JPM2024 #Biotech #Leadership #Innovation #JoePayne #ArcturusTherapeutics